FdaApplication
NDA 203971
Identifiers
- fda_app_no: NDA203971
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2013-05-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XOFIGO | RADIUM RA-223 DICHLORIDE | 162mCi/6ML (27mCi/ML) | SOLUTION;INTRAVENOUS |
1 product